Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
収録刊行物
-
- Leukemia
-
Leukemia 28 (10), 1988-1992, 2014-05-06
Springer Science and Business Media LLC